March 26, 2021 07:30 AM EDTUpdated 02:33 PM

Another 4 pharmas make the fabled Nasdaq leap, with combined raise rapidly approaching $4.5B

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.

The IPO train is once again full-steam ahead …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

An­oth­er 4 phar­mas make the fa­bled Nas­daq leap, with com­bined raise rapid­ly ap­proach­ing $4.5B